PNPLA3 and metabolic dysfunction-associated steatotic liver disease: This is not necessarily true for hepatic retinyl esters as individuals homozygous for the PNPLA3-I148M risk allele are predisposed to NAFLD and disease progression, while their hepatic retinyl palmitate levels are increased compared to NAFLD-I148 (protective allele) carriers.